Header cover image

Australian Pharmaceuticals & Biotech Breakout Stocks

Results

1

1 new

Stocks where the price continues to rise after more than a year of consistent gains.

1 companies

Nyrada

Market Cap: AU$158.0m

A pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases.

New

NYR

AU$0.69

7D

24.5%

1Y

114.1%